Study Title: A Randomized, Open-label, Phase 3 Study of Sacituzumab Govitecan Versus Treatment of Physicians Choice in Participants With Endometrial Cancer Who Have Received Prior Platinum-Based Chemotherapy and Anti-PD-1/PD-L1 Immunotherapy
For more information about the trial above please contact the study team:Medical University of South CarolinaPrincipal Investigator, Orr, Brian, at orrb@musc.edu.Study Coordinator, Knox, Crystal, at knoxc@musc.edu.Trial opened at the following institutions: Medical University of South Carolina